2026 Cornelis J. M. Melief: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	136	186	173	6	6	513	71004
Medicine	136	1974	1839	75	74	514	70996

Cornelis J. M. Melief publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Cornelis J. M. Melief sits on this spectrum.

62 publications 807+

This scientist: 513 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Cornelis J. M. Melief D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Cornelis J. M. Melief sits on this spectrum.

40 D-Index 157+

This scientist: 136 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

2026 - Research.com Immunology in Netherlands Leader Award
2025 - Research.com Immunology in Netherlands Leader Award
2023 - Research.com Medicine in Netherlands Leader Award
2022 - Research.com Immunology in Netherlands Leader Award

Overview

Cornelis J. M. Melief is affiliated with ISA Pharmaceuticals in the Netherlands. Their research primarily focuses on Medicine, with notable contributions across several subfields including Infectious Diseases, Nutrition and Dietetics, Neurology, Immunology, and Oncology.

The scientist's recent publications cover a range of topics related to immunotherapy, infectious disease responses, and cancer. Noteworthy papers include:

Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention (2020, Toxicology Reports)
Editorial: Novel Strategies for Anti-Tumor Vaccines (2020, Frontiers in Immunology)

The topics addressed in their work encompass:

COVID-19 Clinical Research Studies
Vitamin C and Antioxidants Research
Long-Term Effects of COVID-19
Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
Vaccines and Immunoinformatics Approaches

Frequent co-authors who have collaborated with Melief include Aikaterini Nasi, Stéphanie McArdle, Gustav Gaudernack, Gabriel Westman, and Johan Rockberg.

The venues where Melief has published include:

Toxicology Reports
Frontiers in Immunology

Best Publications

B lymphocytes secrete antigen-presenting vesicles.

G Raposo;H W Nijman;W Stoorvogel;R Liejendekker

4131
Citations
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

S. P. Schoenberger;R. E. M. Toes;E. I. H. Van Der Voort;R. Offringa

3327
Citations
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

2186
Citations
CD4 + T cell help in cancer immunology and immunotherapy

Jannie Borst;Tomasz Ahrends;Nikolina Bąbała;Cornelis J. M. Melief

1609
Citations
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.

R. P.M. Sutmuller;L. M. Van Duivenvoorde;A. Van Elsas;T. N.M. Schumacher

1533
Citations
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

J I Mayordomo;T Zorina;W J Storkus;L Zitvogel

1397
Citations
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

1310
Citations
Dendritic cell immunotherapy: mapping the way

Carl G Figdor;I Jolanda M de Vries;W Joost Lesterhuis;Cornelis J M Melief

1278
Citations
Therapeutic cancer vaccines

Cornelis J.M. Melief;Thorbald van Hall;Ramon Arens;Ferry Ossendorp

1275
Citations
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

A. Sette;A. Vitiello;B. Reherman;P. Fowler

1098
Citations
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

M. C. W. Feltkamp;H. L. Smits;M. P. M. Vierboom;R. P. Minnaar

1033
Citations
Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

Ferry Ossendorp;Erica Mengedé;Marcel Camps;Rian Filius

764
Citations
Vaccines for established cancer: overcoming the challenges posed by immune evasion.

Sjoerd H. van der Burg;Ramon Arens;Ferry Ossendorp;Thorbald van Hall

743
Citations
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

Cornelis J.M. Melief;Sjoerd H. van der Burg

722
Citations
Decreased tumor surveillance in perforin-deficient mice.

M. F. Van Den Broek;D. Kagi;F. Ossendorp;R. Toes

712
Citations
Cancer Immunotherapy by Dendritic Cells

Cornelis J.M. Melief

677
Citations
CD4 T cells and their role in antitumor immune responses.

René E.M. Toes;Ferry Ossendorp;Rienk Offringa;Cornelis J.M. Melief

663
Citations
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.

Jasper G. van den Boorn;Debby Konijnenberg;Trees A.M. Dellemijn;J.P. Wietze van der Veen

631
Citations
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides

Sander Zwaveling;Sandra C. Ferreira Mota;Jan Nouta;Mark Johnson

596
Citations
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.

Diehl L;den Boer At;Schoenberger Sp;van der Voort Ei

596
Citations

Frequent Co-Authors

Sjoerd H. van der Burg Leiden University Medical Center

Rienk Offringa German Cancer Research Center

Ferry Ossendorp Leiden University Medical Center

Jan W. Drijfhout Leiden University Medical Center

René E. M. Toes Leiden University Medical Center

Marij J. P. Welters Leiden University Medical Center

Gemma G. Kenter Vrije Universiteit Amsterdam

W. Martin Kast University of Southern California

Kees L. M. C. Franken Leiden University Medical Center

Gert Jan Fleuren Leiden University Medical Center

External Links

Personal website of Cornelis J. M. Melief

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related fields such as nursing and psychiatric mental health can open diverse career opportunities. Many choose to pursue advanced nursing degrees, which often blend clinical knowledge with research skills relevant to immunological health.

Those considering a nursing pathway might find programs listed under easiest nurse practitioner degree programs helpful when seeking flexible and accessible options. These programs typically offer streamlined curricula that can accommodate working professionals.

Specifically, for those interested in mental health aspects tied to immune function, the best psychiatric mental health nurse practitioner programs online stand out for their strong clinical placement rates, ensuring practical experience alongside theoretical study.

Cost is also a vital consideration. Prospective students can explore the cheapest pmhnp programs online to find budget-friendly options without compromising quality. Affordability combined with reputation can make a significant difference in educational outcomes.

Finally, understanding potential earnings is essential when planning a career. The how much does a dnp make resource offers valuable insights into Doctor of Nursing Practice salaries by state, helping graduates forecast their financial future post-degree.